IFB 2027 Epinephrine Auto-Injectors
Open State & local contract opportunity Posted
- Solicitation number
- 2140592
- State
- New York
- Responses due
Opportunity facts
- Jurisdiction
- Points of contact
-
- Kathleen Belmonte kathleen.belmonte@ocfs.ny.gov (518) 473-5644
- Phil Ingram phil.ingram2@ocfs.ny.gov (518) 486-6333
Updated .
About this opportunity
New York State Office of Children and Family Services is soliciting bids under IFB 2027 for up to 72,000 twin-pack epinephrine auto-injectors for eligible child care programs statewide, with written questions due November 19, 2026 and bids due December 16, 2026 at 4:00 p.m. Eastern Time. No set-aside or preference program applies. The listing's goal fields show 0.00% for MBE, WBE, and SDVOB, while the full IFB cites agency-wide goals of 30% MWBE and 6% SDVOB participation that contractors are encouraged to pursue.
The scope covers three dosage strengths of 24,000 twin packs each: 0.1 mg for children weighing 16.5–33 pounds, 0.15 mg for 33–66 pounds, and 0.3 mg for more than 66 pounds. The procurement supports the Non-Patient Specific Auto-Injector initiative under Elijah's Law for licensed and registered child care programs serving children ages 6–12. Shipping to FOB Destination points throughout New York State is included in the bid price.
Bidders must be authorized to dispense the products in New York or become authorized upon award, be a manufacturer, authorized representative, wholesaler, or pharmacy, and have at least one year of experience dispensing all three dosages. The contractor must interface with OCFS's Child Care Facility System through .NET Core 10 JSON REST APIs and integrate with the Professional Development Program training system to validate device requests. Products carry a two-year defect warranty from acceptance, and recalled devices must be replaced at no cost. Required insurance includes workers' compensation, professional liability of $1 million per occurrence and $2 million aggregate, and data breach and cyber liability of $2 million.
Total cost for the two-year term may not exceed $15 million, and bids above that cap are subject to rejection. The contract runs for up to two years following Office of the State Comptroller approval, with an anticipated start date of February 1, 2027. The incumbent is H.F. Acquisitions Co LLC, dba Healthfirst, a Service-Disabled Veteran-Owned Business. The single contract goes to the lowest-cost qualified bidder that meets all mandatory specifications and vendor responsibility requirements. Bidders must submit the OCFS-4822 Procurement Lobbying Act certification and the bidders certified form, and bid sheets go by email to RFQ@ocfs.ny.gov. OCFS contact is Kathleen Belmonte.
Opportunity text
Responders must be able to provide up to 72,000 twin pack auto-injectors of varying dosages for a total cost not to exceed $15 million for the two year period. Auto Injectors must be delivered to eligible child care programs throughout New York State. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: H.F. Acquisitions Co LLC, dba Heatlthfirst Service-Disabled Veteran-Owned Business (SDVOB) SDVOB Goal: 0.00% Minority / Women Business Enterprise contracting goals (MWBE) MBE Goal: 0.00% WBE Goal: 0.00%
Files
| File | Type | Posted |
|---|---|---|
| 2027 Epinephrine IFB Auto-Injectors - Final.pdf | ||
| Attachment #1 Financial Response Bid Sheet 2027 Auto-Injector.xlsx | XLSX spreadsheet | |
| IFB 2027 Attach #2 Auto Injector Bidders Certifed Form.docx | DOCX document | |
| OCFS-4822 Procurement Lobbying Act Ceritifcation.dot | DOT file | |
| OCFS-0910 2027 Epinephrine Auto-Injector.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity